RENAL CELL CANCER

Clinical trials for RENAL CELL CANCER explained in plain language.

Never miss a new study

Get alerted when new RENAL CELL CANCER trials appear

Sign up with your email to follow new studies for RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 5 Completed 4 Terminated 1

New combo therapy aims to shrink advanced liver and kidney tumors

Disease control Not yet recruiting

This study tests a new drug called WGI-0301 combined with the immunotherapy nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe and can shrink tumors. About 230 adults aged 18 to 75 will take part, and the study does not use a p…

Matched conditions: RENAL CELL CANCER

Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC

RENAL CELL CANCER

Get alerted when new RENAL CELL CANCER trials appear

New combo therapy aims to shrink advanced liver and kidney tumors